Items Tagged ‘Mayo Clinc’s Center for Individualized Medicine’
April 16, 2013
Researchers call for national standards for genomic data use
Better standards are needed for how discoveries in genomic medicine are found and recorded as health information technology develops, according to researchers from Harvard and the Mayo Clinic who published a viewpoint in the Journal of the American Medical Association last week…In an announcement touting the viewpoint, Gianrico Farrugia, M.D., director of Mayo Clinic’s Center for Individualized Medicine, called the researchers’ work […]
Tags: Dr. Gianrico Farrugia, FierceHealthIT, genomic data, genomic medicine, health information technology, Individualized medicine, Journal of the American Medical Association, Mayo Clinc's Center for Individualized Medicine, national standards
April 10, 2013
Diagnostics firm Cancer Genetics goes public
Cancer Genetics, a diagnostics firm focused on developing genomic-based oncology tests, made its initial public offering at a time of rapid growth in the diagnostic testing market. The 50/50 venture has not been formally established but both organizations have agreed to its development, a Mayo spokesman said. Cancer Genetics will provide capital investments and Mayo will […]
Tags: Cancer Genetics, diagnostics, Dr. Gianrico Farrugia, Individualized medicine, Mayo Clinc's Center for Individualized Medicine, Modern Healthcare, oncology tests
February 15, 2012
Mayo Clinic signs California genome sequencing firm
To support its move toward personalized medicine, Mayo Clinic is joining forces with a California genome sequencing company. Complete Genomics Inc. announced Monday that Mayo Clinic’s Center for Individualized Medicine had chosen it to provide whole human genome sequencing on an outsource basis. Mayo Clinic will continue to do its own sequencing also, but this […]
Tags: Center for Individualized Medicine, Complete Genomics Inc., Dr. Gianrico Farrugia, human genome sequencing, Mayo Clinc's Center for Individualized Medicine
February 14, 2012
Complete Genomics To Provide Services To Mayo Clinic; Shares Up
Complete Genomics Inc. (GNOM) was chosen by Mayo Clinic’s Center for Individualized Medicine to provide whole human genome sequencing outsourcing services, to supplement the nonprofit research hospital’s in-house gene-sequencing laboratory. Complete Genomics shares rose nearly 24% to $4.07 in recent premarket trading. Through Friday’s close, the stock is up nearly 49% from its all-time low […]
Tags: Complete Genomics Inc., GNOM, human genome sequencing outsourcing services, Illumina Inc., ILMN, Mayo Clinc's Center for Individualized Medicine, Roche Holding Ltd., ROG.VX